Caco-2 cells, closed intestinal loops and a Barrett's esophagus rat model to test transduction of adenoviruses expressing green fluorescent protein. We observed a decreased adenoviral transduction from 18.6 to 2.3% in undifferentiated and differentiated Caco-2 cells, respectively. This could be improved by the use of the mucolytic agent N-acetylcysteine (NAC) and the polycation diethylaminoethyl-dextran (DEAE-dextran), which improved transduction in differentiated cells five-and ten-fold, respectively. Also an RGD-retargeted adenovirus showed an improved transduction in differentiated cells. In closed intestinal loops adenoviral transduction was limited and the use of NAC and DEAE-dextran or RGD targeting had little effect. The Barrett's esophagus rat model consisted of an esophagojejunostomy, which results in a Barrett's esophagus and esophageal tumors within 6 months. Adenoviral transduction in this model was limited and mainly localized in the basal layer of normal esophagus and stromal tissue of a Barrett's segment. We conclude that although the adenovirus shows promising results in vitro, the current adenoviral vectors are probably not suitable for patients with Barrett's esophagus.
B
arrett's esophagus is defined as the presence of intestinal metaplasia in the esophagus, which has replaced its native squamous epithelium. Patients with a Barrett's esophagus have an increased risk of developing esophageal adenocarcinoma and are therefore advised to enter a surveillance program. 1 Barrett's esophagus and its development into esophageal adenocarcinoma is strongly associated with gastroesophageal reflux disease and for the last three decades an enormously rising incidence of these conditions has been observed. 2 In time there is high chance for the development of dysplasia in a Barrett's esophagus and various treatment modalities are being developed to manage this condition. Medical treatment consists of acid suppressive therapy, but this has not been proven to be effective for regression of dysplasia. When high-grade dysplasia has developed, a surgical resection is generally advocated, which is accompanied by a significant mortality and morbidity. Therefore, several endoscopic treatment modalities, such as photodynamic therapy and endoscopic mucosal resection, are under development for patients with dysplasia in a Barrett's esophagus. 3 Gene therapy could potentially play an additional role for these local ablative treatment modalities of dysplastic lesions in a Barrett's esophagus. As a model for this approach, it has been shown that it is feasible to transduce DNA-liposomes in the rat esophagus with the use of a balloon catheter. 4 The adenovirus is the most commonly used vector for cancer gene therapy as it is easy to modify and can be easily produced in large quantities. Moreover, a large gene of interest can be cloned into it. In the setting of treatment of dysplasia in a Barrett's esophagus, the adenoviral vector could be applied locally by endoscopic means. For the feasibility of this approach it is important to analyze the transduction efficacy of the adenovirus in intestinal models and to find methods to improve it. Mucus, which covers the columnar-lined Barrett's esophagus, and the level of differentiation could be a potential hurdle for adenoviral transduction efficacy.
Several models can be used to study Barrett's esophagus. As Barrett's esophagus is defined as intestinal metaplasia in the esophagus, we chose intestinal models to study adenoviral transduction. The human intestinal cell line Caco-2 is a commonly used in vitro model for intestinal epithelium. 5 Originating from a colon adenocarcinoma it has the unique ability to differentiate, exhibiting morphological characteristics comparable to intestinal cells. 6 For in vivo studies, rat-closed intestinal loops are readily available and easy to work with. Finally, there is the Barrett's esophagus rat model. With a surgically applied side-to-side esophago-jejunostomy, gastric and duodenal reflux is induced, which results in a Barrett's segment 1 year after the procedure. 7 It is an elaborate model in which the animals suffer from a high mortality and morbidity.
N-acetylcysteine (NAC) is a mucolytic agent, which might enhance gene transfer by dissolving the mucus layer in the gastrointestinal tract. Diethylaminoethyl-dextran (DEAE-dextran) is a polycation, which has been used to enhance both viral and nonviral gene transfer. For cell entry, the adenovirus is dependent on the presence of integrins and the coxsackie-adenovirus receptor (CAR) on the surface of the host cell. 8 In order to improve cell entry, genetic targeting is an attractive option. An adenovirus in which the peptide Arg-Gly-Asp (RGD) is incorporated into the HI loop of the viral fiber knob revealed an improved transduction in different cancer cell lines, especially in cells with limited CAR expression. 9, 10 In the study described in this paper, we investigated the transduction capacity of adenoviral vectors in vitro in differentiated Caco-2 cells and in vivo in a rat model of closed intestinal loops and a Barrett's esophagus rat model. In an attempt to increase this transduction capacity, we analyzed the impact of several measures, including NAC, DEAE-dextran and genetic targeting with RGD.
Materials and methods

Cell line
The Caco-2 cell line was obtained from the American Type Culture Collection (Manassas, VA). The cell lines were propagated every 3 days and cultured in a medium consisting of Dulbecco's-modified Eagle's medium (DMEM) supplemented with L-glutamine (300 mg/ml), 10% heat-inactivated fetal calf serum, penicillin (100 U/ ml) and streptomycin (100 mg/ml). To assess adenoviral transduction in cell lines, 5 Â 10 4 cells/well were plated in a 48-well plate at which amount the cells reached confluence overnight. Undifferentiated cells were defined as Caco-2 cells just reaching confluence after seeding. Differentiation was achieved by a long-term culture of 2 weeks, refreshing medium every 2 days. Villin expression as determined by Western blotting was used to assess the degree of differentiation.
Western blotting
Caco-2 confluent layers from day 0 (after reaching confluence), day 7, 14 and 21 were lysed by adding 0.40 ml of ice-cold homogenizing buffer (20% glycerol, 0.1 M Tris-HCl, and 10 mM EDTA, pH 7.4) containing 1% protease inhibitor cocktail (Sigma, St Louis, MO). A sample of mouse ileum was used as a positive control. The cells were frozen and thawed in À801C three times and sonicated for 10 seconds. Homogenates were dissolved in a sample buffer (2% sodium dodecyl sulfate (SDS), 5% sucrose, 5% 2-mercaptoethanol and 50 mM Tris-HCl, pH 6.8) to a final concentration of 25 mg/40 ml and subsequently separated on a 6% SDS-polyacrylamide gel. Villin was detected using a mouse monoclonal antibody (Chemicon, Temecula, CA) and horseradish peroxidase anti-mouse (Transduction Laboratories, Lexington, KY) was used as a secondary antibody. The immunocomplex was detected with the Lumilight-plus chemiluminescence detection system and the Lumi imager (Roche Diagnostics, Mannheim, Germany).
Adenoviral vectors
An E1-deleted adenovirus (Ad) type 5 expressing green fluorescent protein (GFP) under control of a CMV promoter, and an RGD-targeted adenovirus (AdRGDGFP), with an RGD peptide cloned into the HI loop of the fiber knob, were kindly provided by Dr V Krasnykh (University of Alabama, Birmingham, AL). 9 AdRGDGFP was also E1-deleted and also contained the GFP reporter gene under control of a CMV promoter. The viruses were propagated and plaque titered on the permissive cell line 293 using standard techniques. 11 The virus titer was expressed as plaque forming units (pfu). Purification was performed by centrifugation on a CsCl gradient and all virus aliquots were stored at À801C until use.
In vitro adenoviral transduction
The undifferentiated and differentiated Caco-2 cells were transduced with the different adenoviral vectors with a multiplicity of infection (MOI) of 10. The medium was removed and the vector was applied in 100 ml of PBS. After 1 hour of incubation the mixture was removed and fresh culture medium was added. At 24 hours after transduction the efficacy was assessed by measuring GFP expression using flowcytometry. The cells were prepared for flowcytometry as follows. The cells were trypsinized and fixed with 4% paraformaldehyde. Then they were pelleted at 1200 rpm for 5 minutes and resuspended in PBS with 1% bovine serum albumin. Resuspended cells were used for flowcytometry (Calibrite; Becton Dickinson Immunocytometry Systems; Franklin Lakes, NJ). At least 10,000 cells were counted and data on the number of transduced cells were obtained by setting a 1% quadrant marker for nonspecific staining in the nontransduced cells.
In order to improve transduction the cells were either washed or incubated with 20 or 100 mM NAC. For washing, NAC was added to the cells for 15 minutes and after washing with PBS, the adenovirus was added. For incubation the adenovirus was dissolved in NAC and incubated with NAC on the cells for 1 hour. For the effect of a polycation-assisted gene transfer, the adenovirus was dissolved in DEAE-dextran (Sigma-Aldrich, St. Louis, MI) in a concentration of 10 mg/ml and the mixture was allowed to incubate at room temperature for 30 minutes for optimal complex formation. Thereafter the mixture was added upon the cells for transfection for 1 hour, at which time point the mixture was replaced by medium. Finally, washing cells with NAC 20 mM was combined with mixing the adenovirus with DEAE-dextran.
In vivo adenoviral transduction in closed intestinal loops
Animals. For this experiment, 400-500 g male SpragueDawley rats (Harlan CBP, Austerlitz, The Netherlands) were used. The animals were kept on a 12-hour day-night cycle with free access to rat chow (AM II, Hope Farms, Woerden, The Netherlands) and tap water. Solid food was withdrawn 1 day prior to surgery. Chow was provided again 2 hours after surgery. In this experiment four animals were used and per animal two intestinal loops were studied. . Via a median laparotomy, an appropriate proximal segment of the jejunum was identified and carefully brought to the surface of the cavity. Per rat, two fluid-sealed segments of 5 cm were created by placing four small atraumatic vena clamps. In one animal AdGFP was used with DEAEdextran in one loop and without DEAE-dextran in the other loop. In another animal AdRGDGFP was studied in combination with or without DEAE-dextran. In the other two animals the use of NAC was studied in similar experiments in four intestinal loops. In these animals, NAC 20 mM was installed for 15 minutes before installation of the adenovirus. After removal of the NAC, the loops were flushed with PBS, and then installed with AdGFP or AdRGDGFP, with or without the use of DEAE-dextran. In all experiments the adenovirus was introduced at a dose of 1 Â 10 9 pfu in 1 ml PBS or 1 ml DEAE-dextran at room temperature (in order to moderately distend the segment) using a 30-gauge needle fixed to a 2 cm 3 syringe. The virus was allowed to incubate for 1 hour after which the installed virus was removed and the segments were flushed with PBS. The animals were allowed to wake up and resume normal activity. After 24 hours, the animals were killed by a cervical dislocation. The jejunal segments were opened longitudinally and the specimen was curled up from proximal to distal (Swiss roll) and fixed in formalin. The lungs and liver were excised and fixed separately. Thereafter, the specimens were embedded in paraffin wax and prepared for histological examination. Blood samples were taken, when the animals were killed, and tested for the liver enzymes (ASAT, ALAT, bilirubin, gGT) by routine clinical chemical tests on a Hitachi 912 analyzer.
In vivo transduction of a rat Barrett's esophagus
In 10 male Sprague-Dawley rats (Harlan CBP, Austerlitz, The Netherlands), a side-to-side esophago-jejunostomy without gastrectomy was performed under general inhalation-anesthesia (Isoflurane, N 2 O and O 2 ) inducing duodeno-gastro-esophageal reflux to create a Barrett's esophagus as previously described. 7 In brief, via a median laparotomy the jejunum was anastomosed side-to-side with the distal esophagus, with an anastomotic diameter of 1 cm. For 12 months, these animals were fed a regular diet and had free access to tap water. Three 300 g animals were used for the current experiments. For this approach only AdGFP was used and not the retargeted AdRGDGFP. The duodenum was clamped just below the stomach and a tube was placed in the esophagus via a cervical incision. The compartment of esophagus and stomach was flushed with NAC 20 mM and 15 minutes thereafter, 1 Â 10 9 pfu/ml of adenovirus was installed until the compartment of stomach and esophagus was filled. For this purpose the installation of 3 ml of the virus was needed. The virus was left in situ for 1 hour after which the lumen was flushed with PBS. At 24 hours after installation the animals were killed and the esophagus was processed as described in the previous section.
Immunohistochemical analysis
To assess the transduction of adenovirus in the different specimens, immunohistochemical analysis for GFP expression was carried out using a three-step detection method. The paraffin-embedded biopsies were dewaxed, rehydrated in graded alcohols and endogenous peroxidase activity was blocked with 0.3% hydrogen peroxide. Nonspecific staining was blocked with 10% normal goat serum. Then the slides were incubated overnight with a mouse monoclonal anti-GFP JL-8 (Clontech, Palo Alto, CA) in a 1:1000 dilution. This step was followed by incubation with rabbit anti-mouse HRP in a 1:100 dilution (Dako, Glostrup, Denmark) and a subsequent incubation with streptABComplex/HRP (Dako) was performed according to the manufacturer's instructions. Peroxidase activity was measured with a diaminobenzidine reaction. An experienced GI pathologist evaluated the samples. For each segment the number of transduced epithelial and stromal cells were counted.
Statistics
The Animal Ethics Committee of the Academic Medical Center, University of Amsterdam, approved all experiments. All in vitro experiments were carried out in triplo and results are expressed as the mean value and its standard deviation. Differences in in vitro transduction of the cell lines were tested for significance using the Student's t-test. All tests were two-sided and a P-value o.05 was considered significant.
Results
In vitro adenoviral transduction
Differentiation of the Caco-2 cells was assessed by the expression of villin, as shown by Western blotting. At 2 days after seeding of Caco-2 cells there was no expression of villin, while after 7 days there was villin expression, which had further increased 14 and 21 days after seeding (Fig 1) . As the macroscopic quality of the cell deck was poor at 21 days, as compared to 14 days, it was decided to use 14 days cultured Caco-2 cells for transduction experiments.
To determine the transduction efficacy of differentiated versus undifferentiated Caco-2 cells they were infected with AdGFP. Transduction efficacy of AdGFP was markedly reduced upon differentiation of the Caco-2 cells. Undifferentiated and differentiated Caco-2 cells had an adenoviral transduction rate of 18.6% (SD; 0.8%) and 2.3% (SD; 0.4%), respectively. The results of one representative experiment are shown in Figure 2 . In order to improve transduction efficacy of differentiated cells, they were washed with NAC and PBS, respectively. Washing cells with NAC, in a concentration of 20 mM, resulted in a five-fold improved transduction compared to the washing or incubation with PBS (Fig 3) . In contrast to NAC 20 mM washing, incubation of AdGFP with NAC 20 mM resulted in hardly any transduction at all. Also washing or incubation of cells with NAC 100 mM resulted in a significantly impaired transduction of differentiated cells as compared to PBS-treated cells.
DEAE-dextran was used in order to study the effect of polycatiation on transduction of differentiated cells. Incubation of the adenovirus with DEAE-dextran resulted in a 10-fold improved transduction of differentiated Caco-2 cells (Fig 4) . In undifferentiated Caco-2 cells no improvement was found with the use of DEAE-dextran. A combination of NAC 20 mM washing and the use of DEAE-dextran did not have an improved transduction efficacy compared to either one of these modalities (data not shown).
As differentiated cells have a decreased CAR expression, the RGD-retargeted adenovirus was tested on differentiated cells, as this vector can transduce cells irrespective of the presence of CAR. In undifferentiated cells the RGD-retargeted adenovirus had a 2.5-fold increased transduction compared to AdGFP, where as this transduction ratio increased to five-fold in Figure 4 Influence of incubation of the adenovirus with the polycation DEAE-dextran on adenoviral transduction efficacy in undifferentiated and differentiated Caco-2 cells. *Po.05 DEAEdextran versus PBS-incubated adenovirus according to Student's t-test. differentiated cells (Fig 5) . The transduction efficacy of AdRGDGFP in differentiated cells was similar to the transduction of AdGFP in undifferentiated cells.
In vivo transduction in closed intestinal loops
As washing with NAC 20 mM, incubation with DEAEdextran and RGD retargeting showed increased transduction in vitro, all these modalities, and combinations of these, were tested in vivo in closed rat intestinal loops. Overall, transduction was very limited in these experiments (Fig 6) . In vivo transduction in rat Barrett's esophagus A Barrett's esophagus model was established by an esophago-jejunostomy, inducing reflux of both gastric and duodenal contents. In all, 10 animals, from a previously reported study, had a 1 year follow-up after surgery. 7 In nine of these animals Barrett's mucosa was recognized in the esophagus with a median length of 10 mm (range 0-22). Squamous cell carcinoma was found in six animals and adenocarcinoma was found in seven animals. Three of these 10 animals were used for the present transduction experiments. All three animals had a Barrett's segment and squamous hyperplasia in the esophagus. Two animals had lesions in the esophagus, resembling squamous cell carcinoma and one animal had a well-differentiated adenocarcinoma. Transduction of the adenovirus was very limited and mainly localized in stromal cells (Fig 7) . Two animals had some transduction in the basal layer of the normal squamous esophagus. The third had some transduction in stromal tissue surrounding Barrett's mucosa. No transduction was observed in any of the tumors. Liver and lungs had a histologically normal aspect and staining for GFP was completely negative. The liver enzymes, 24 hours after installation of the virus, were within the normal range.
Discussion
The gastrointestinal tract could be an interesting target for gene therapy interventions, as it comprises a large surface, which can be easily approached by endoscopic techniques. Barrett's esophagus is also a potential target for gene therapy applications. Patients with high-grade dysplasia in a Barrett's esophagus could be treated by local endoscopic administration of a gene-delivering vector, eradicating Barrett's mucosa. In a previous study we reported on the adenoviral transduction in an esophageal explant model. 12 In this model the transduction in human Barrett's intestinal metaplasia was limited. Several mechanisms might have caused this limited transduction and in the current study we explored different modalities in an attempt to improve transduction of intestinal cells. This was investigated in vitro in differentiating Caco-2 cells and in vivo in intestinal loops and in a rat model of Barrett's esophagus. We found that adenoviral transduction is reduced upon differentiation of Caco-2 cells, but that it can be improved by using NAC or DEAE. Also the RGD-retargeted adenovirus showed an improved transduction in differentiated cells. These applications were also explored in the in vivo models but in that setting the transduction was very limited and could not be improved in contrast to the in vitro setting.
Intestinal epithelium has been proven a difficult target for gene therapy approaches. Earlier studies reported on nonviral transduction of DNA plasmids with liposomes. 4, 13, 14 Transduction, however, was limited and lasted for only a short time period. Therefore viral vectors, most commonly adenoviral vectors, were explored in order to achieve an improved and longer lasting intestinal gene transfer. In most of these studies the adenovirus was administered locally in intestinal loops without any adjuvant agents. [15] [16] [17] These studies suggested a favorable transduction of adenovirus in intestinal epithelium. However, in all these studies Lac-Z, which encodes for the enzyme b-galactosidase, was used as a reporter gene. As this enzyme has a considerable endogenous staining in the intestine, application of this reporter gene might have overestimated the intestinal transduction rates. 18 For instance, when GFP was used as a reporter gene, a very limited intestinal transduction of the adenovirus was observed. 19 More recent studies examined the use of different adjuvants in order to increase adenoviral transduction in the intestine. PEGylation has been shown to increase adenoviral transduction in the intestine 10-40 fold. 20 Also the use of beta-cyclodextrin has been shown to improve the adenoviral transduction of the intestine both in vitro and in vivo. 21 The polycation DEAE-dextran has been studied in the setting of nonviral intestinal gene delivery and showed an improved transduction of DNA in the colon. 22 The combination of DEAE-dextran with adenovirus has been used for pulmonary gene transfer and showed favorable results. 23 Both the adenovirus and the apical surface of differentiated cells are negatively charged, which hampers efficient attachment. 24 A polycation forms a complex with the adenovirus improving subsequent attachment and transduction of the adenovirus. To our knowledge, the specific combination of adenovirus and DEAE-dextran has not yet been studied for intestinal gene transfer yet. In the present study we observed an eight-fold increased transduction in differentiated Caco-2 cells when the adenovirus was mixed with DEAE-dextran. In undifferentiated cells, transduction efficacy was already relatively high and did not improve with DEAE-dextran. Unfortunately, the promising in vitro results could not be confirmed in the in vivo setting where transduction was very limited in the intestinal loops and did not improve with DEAE-dextran.
Mucus is a potential hurdle for intestinal gene transfer. NAC is a mucolytic agent, which exhibited an improved gene transfer in pulmonary epithelium for both viral and nonviral vectors. 25, 26 Studies on the effect of mucus and the role of NAC in gene transfer of the gastrointestinal tract are limited. An earlier study showed that NAC removed the mucus between the villi, but no attempt of gene transfer was made. 27 In another study NAC was studied in vitro in a coculture model, where it failed to accomplish an improved transduction rate of a nonviral vector. 28 In the present study, we studied the role of NAC for adenoviral intestinal gene transfer in vitro and in vivo. When differentiated Caco-2 cells were washed with NAC 20 mM we observed an increased transduction, which is in contrast to the in vivo results that did not show any improvement. The most important mechanism of NAC is the disruption of disulfide bonds of glycoproteins in mucus, by which the mucus is dissolved. As Caco-2 cells produce little mucus, other mechanisms could be responsible for the improved transduction in these cells. NAC also has an important effect on the cellular redox state by its reducing effect on glutathione. This reducing effect could enhance the activity of adenoviral cysteine protease and activate several transcription factors leading to an improved intracellular release of adenoviral DNA and improved transcription, respectively. 29 Upregulation of CAR has also been observed after incubation with NAC.
30 Surprisingly, transduction rate was markedly reduced when the adenovirus was incubated with NAC. Disulfide bonds in the adenovirus could be disrupted by NAC leading to inactivation of the virus.
Several factors could be responsible for the limited intestinal transduction of the adenovirus. The tight structure of the epithelium is probably the most important limiting factor. The intestinal epithelium consists mainly of enterocytes, which are highly differentiated cells with a low rate of proliferation, apart from a small area of stem cells. Walter et al studied adenoviral transduction in differentiating Caco-2 cells and observed an impaired transduction upon differentiation. 17 In that study, however, undifferentiated Caco-2 cells were nonconfluent which results in a larger surface area per cell compared to differentiated confluent cells. In our study, we used confluent undifferentiated cells and observed a dramatically decreased adenoviral transduction upon differentiation of Caco-2 cells. The formation of tight junctions may prevent the access to the basolateral membrane of an apical delivered vector. CAR is an important receptor for attachment of the adenovirus and it has been shown to be absent on the apical side of differentiated cells, which is the reason for impaired adenoviral transduction of differentiated epithelial cells. 31 Integrins are also important for adenoviral attachment and they are generally not present on the apical surface of differentiated enterocytes. 32 The RGD-retargeted adenovirus is less dependent on the presence of CAR and could therefore be an interesting candidate for transduction in differentiated cells. 9 Indeed, in differentiated cells the RGD-retargeted virus had a relatively increased transduction compared to the native adenovirus. In contrast to these in vitro results, the in vivo results with the RGD-retargeted virus were disappointing. An additional problem could be the relative instability of the adenovirus in the gastrointestinal tract. Previous studies have shown that the adenovirus is rapidly degraded in gastrointestinal contents. 20 We tried to prevent this by extensive flushing and by refraining from giving the animals from solids for 24 hours in order to minimize the mixture of the adenovirus with gastrointestinal contents.
In conclusion, we studied adenoviral gene transfer in several models of Barrett's esophagus. The in vitro results showed a decreased transduction upon differentiation of the Caco-2 cells. The use of NAC, DEAE-dextran and a RGD-retargeted adenovirus all showed promising results in this in vitro model. In the subsequent in vivo experiments, however, transduction efficacy was limited and did not improve by any of the techniques used. We conclude that the adenovirus might not be the appropriate vector for intestinal gene transfer and that in vitro results correlate poorly to in vivo results.
